When was Infraredx founded?

Infraredx was founded in 1998 and raised its 1st funding round 4 years after it was founded.

Where is Infraredx located?

Infraredx is headquartered in Burlington, United States. It is registered at Bedford, Massachusetts.

How many employees does Infraredx have?

As of May 31, 2026, the latest employee count at Infraredx is 95.

Is Infraredx a funded company?

Infraredx is a funded company, having raised a total of $101M across 13 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 2002.

When was the latest funding round of Infraredx?

Infraredx's latest funding was a $***** Conventional Debt round on Nov 05, 2013, with participation from 1 investor.

Where does Infraredx rank among its competitors?

Infraredx ranks 4th amongst 29 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Conavi, which secured $700K in Jan, 2026.

Who are the top competitors of Infraredx?

Infraredx's top competitors include Conavi, Ionetix and Acarix. Among them, Conavi secured the most recent funding round in January, 2026.

Infraredx - 2026 Company Profile, Funding & Competitors

Q: Is Infraredx an acquired company?

Infraredx got acquired by Nipro on Sep 11, 2015.

Company Details

Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes. They are dedicated to conquering vascular disease through innovative solutions. They develop and provide high-resolution intravascular imaging platforms that combine structural views with plaque compositional analysis, offering treatment insights. Their products include HD-IVUS and IVUS+NIRS systems, along with essential accessories. They focus on identifying unstable lipid-core plaques to prevent major adverse cardiac events. They are involved in clinical research, conducting studies to evaluate the safety and effectiveness of their technologies. They aim to optimize the treatment of polyvascular disease patients. They provide educational resources, including webinar sessions and an IVUS app. They are committed to advancing clinical research and innovation in cardiovascular imaging and diagnostics. They are a medical device company focused on improving lives through innovative medical products.

Website: www.infraredx.com/
Social
Registered Address: Bedford, Massachusetts

Key Metrics

Founded Year

1998

Location

Burlington, United States

Stage

Acquired

Total Funding

$101M in 13 rounds

Latest Funding Round

Conventional Debt, Nov 05, 2013, $*****

Investors

Sanderling Ventures & 3 more

Ranked

4^th among 29 active competitors

Employee Count

95 as on May 31, 2026

Similar Companies

Conavi & 40 more

Exit Details

Acquired by Nipro (Sep 11, 2015)

View Infraredx's full profile

Infraredx is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
imaware™ Inc CIN: 82-5045579 , United States, Active	Dec 31, 2016	-	-	-
INFRAREDX, INC CIN: 43502540 , United Kingdom, Active		-	59 (As on Dec 31, 2022)
Infraredx, Inc. CIN: 43502540 , United States, Active	Dec 31, 1999	-	80 (As on Dec 31, 2024)	-

Infraredx got acquired by Nipro on Sep 11, 2015 at an acquisition amount of $*****.

Click here to take a look at Infraredx's acquisition in detail

Infraredx has raised a total funding of $101M over 13 rounds. Its first funding round was on Aug 2002. Its latest funding round was a Conventional Debt round on Nov 05, 2013 for $*****. 1 investor participated in its latest round. Infraredx has 4 institutional investors.

Here is the list of recent funding rounds of Infraredx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 05, 2013	8842589	Conventional Debt	7252927	4189257	4183172	9626001
Aug 22, 2013	2583323	Series C	7022874	7137189	5440516	Nipro
Dec 05, 2011	8630213	Conventional Debt	5197079	6988802	7317601	GE Healthcare Equipment Finance

Access funding benchmarks and valuations. Sign up today!

View details of Infraredx's funding rounds and investors

Infraredx's employee count trend

Infraredx has 95 employees as of May 26. Here is Infraredx's employee count trend over the years:

Uncover Infraredx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Infraredx include Conavi, Ionetix and Acarix. Here is the list of Top 10 competitors of Infraredx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Conavi 2007, Toronto (Canada), Public	A catheter-based ultrasound system for cardiac imaging	$27.7M	FedDev Ontario, MaRS Discovery District & 5 others	66/100
2nd	Ionetix 2009, San Francisco (United States), Series C	Radiopharmaceutical solutions provider specializing in cyclotron technology and targeted alpha therapy	$61.1M	Lilly, Riverland Capital & 1 others	56/100
3rd	Acarix 2009, Kongens Lyngby (Denmark), Public	Provider of a screening device for acoustic coronary artery diseases	$9.97M	Sunstone, Seventure Partners & 2 others	53/100
4th	Infraredx 1998, Burlington (United States), Acquired	Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes	$101M	GE Healthcare Equipment Finance, SLR Investment Corp ... & 2 others	48/100
5th	Cleveland HeartLab 2008, Cleveland (United States), Acquired	Innovative cardiovascular biomarker testing for risk identification and disease prevention	$38.9M	Excel Venture Management, Healthcare Ventures ... & 9 others	47/100
6th	GlyCardial Diagnostics 2017, Barcelona (Spain), Series A	In vitro diagnostic for myocardial ischemia	$2.8M	Ship2B, GENESIS Biomed & 5 others	37/100
7th	Kaminari Medical 2018, Rotterdam (Netherlands), Series A	Developer of diagnostic solution for vulnerable plaque in the coronary arteries	$4.16M	Graduate Ventures, Libertatis Ergo Holding ... & 5 others	35/100
8th	AUM Cardio 2009, Northfield (United States), Series B	Device to detect coronary artery blockage	$11.1M	-	35/100
9th	Ischemia Technologies 1997, Waltham (United States), Deadpooled	Develops, manufactures, and markets in vitro diagnostic tests for cardiac ischemia	$12.7M	GlidePath Partners, KB Partners & 3 others	31/100
10th	POINT Biomedical 1996, San Carlos (United States), Deadpooled	Domain name pointbio.com is for sale via Sedo Domain Parking	$56.4M	Invesco, Saints Capital & 13 others	31/100